| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (585kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-757172
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.75717
Zusammenfassung
Background: The pharmaceutical industry's productivity has been declining over the last two decades and high attrition rates and reduced regulatory approvals are being seen. The development of oncology drugs is particularly challenging with low rates of approval for novel treatments when compared with other therapeutic areas. Reliably establishing the potential of novel treatment and the ...

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

Downloadstatistik